Does ENZALUTAMIDE Cause Product supply issue? 82 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 82 reports of Product supply issue have been filed in association with ENZALUTAMIDE (Xtandi). This represents 0.2% of all adverse event reports for ENZALUTAMIDE.
82
Reports of Product supply issue with ENZALUTAMIDE
0.2%
of all ENZALUTAMIDE reports
9
Deaths
24
Hospitalizations
How Dangerous Is Product supply issue From ENZALUTAMIDE?
Of the 82 reports, 9 (11.0%) resulted in death, 24 (29.3%) required hospitalization.
Is Product supply issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENZALUTAMIDE. However, 82 reports have been filed with the FAERS database.
What Other Side Effects Does ENZALUTAMIDE Cause?
Fatigue (8,891)
Death (6,680)
Malignant neoplasm progression (4,696)
Prostatic specific antigen increased (3,731)
Asthenia (3,589)
Drug ineffective (3,468)
Hot flush (3,144)
Decreased appetite (3,069)
Nausea (2,898)
Dizziness (2,776)
What Other Drugs Cause Product supply issue?
SECUKINUMAB (357)
LENALIDOMIDE (310)
CANNABIDIOL (298)
APREMILAST (266)
HUMAN IMMUNOGLOBULIN G (169)
OFATUMUMAB (149)
ELTROMBOPAG OLAMINE (140)
HUMAN C1-ESTERASE INHIBITOR (117)
OXCARBAZEPINE (109)
CARBAMAZEPINE (98)
Which ENZALUTAMIDE Alternatives Have Lower Product supply issue Risk?
ENZALUTAMIDE vs EPCORITAMAB
ENZALUTAMIDE vs EPCORITAMAB-BYSP
ENZALUTAMIDE vs EPERISONE
ENZALUTAMIDE vs EPHEDRINE
ENZALUTAMIDE vs EPINASTINE